Bluejay Diagnostics (BJDX) Cash & Equivalents (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Cash & Equivalents of $3.7 million for Q1 2026, down 28.66% sequentially from $5.2 million in Q4 2025, and up 18.24% YoY from $3.1 million in Q1 2025.
Bluejay Diagnostics (BJDX) Cash & Equivalents (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Cash & Equivalents for 7 years, with the latest figure at $3.7 million in Q1 2026.
- Quarterly Cash & Equivalents rose 18.24% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 18.24% YoY) and the FY2025 annual result came in at $5.2 million, up 20.06% from the prior year.
- Cash & Equivalents retreated to $3.7 million in Q1 2026 per BJDX's latest filing, from $5.2 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $17.1 million in Q1 2022 and troughed at $2.2 million in Q4 2023.
- A 5-year average of $6.8 million and a median of $5.1 million in 2023 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents jumped 470.33% in 2022, then slumped 78.17% in 2023.
- Over 5 years, Cash & Equivalents stood at $10.1 million in 2022, then plunged by 78.17% to $2.2 million in 2023, then surged by 94.79% to $4.3 million in 2024, then climbed by 20.06% to $5.2 million in 2025, then dropped by 28.66% to $3.7 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $3.7 million, $5.2 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Bluejay Diagnostics | 1.93 Mn | 1.93 Mn | - | 9.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.60 Mn |
| Mar 31, 2026 | 3.68 Mn |
| Dec 31, 2025 | 5.16 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | 5.80 Mn |
| Jun 30, 2024 | 8.06 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Sep 30, 2023 | 5.08 Mn |
| Jun 30, 2023 | 5.10 Mn |
| Mar 31, 2023 | 6.78 Mn |
| Dec 31, 2022 | 10.11 Mn |
| Sep 30, 2022 | 13.29 Mn |
| Jun 30, 2022 | 15.34 Mn |
| Mar 31, 2022 | 17.12 Mn |
| Dec 31, 2021 | 19.05 Mn |
| Sep 30, 2021 | 2.33 Mn |